CN101268058B - 4-苯基-6-取代的-嘧啶-2-腈衍生物 - Google Patents
4-苯基-6-取代的-嘧啶-2-腈衍生物 Download PDFInfo
- Publication number
- CN101268058B CN101268058B CN2006800348456A CN200680034845A CN101268058B CN 101268058 B CN101268058 B CN 101268058B CN 2006800348456 A CN2006800348456 A CN 2006800348456A CN 200680034845 A CN200680034845 A CN 200680034845A CN 101268058 B CN101268058 B CN 101268058B
- Authority
- CN
- China
- Prior art keywords
- pyrimidine
- trifluoromethyl
- nitrile
- phenyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC1(*)C=CC(c2nc(C#N)nc(**)c2)=CC=C1 Chemical compound CC1(*)C=CC(c2nc(C#N)nc(**)c2)=CC=C1 0.000 description 2
- MFRUFRHHUPIEDX-UHFFFAOYSA-N COc(cc1)c(C(F)(F)F)cc1-c1cc(NCCO)nc(C#N)n1 Chemical compound COc(cc1)c(C(F)(F)F)cc1-c1cc(NCCO)nc(C#N)n1 MFRUFRHHUPIEDX-UHFFFAOYSA-N 0.000 description 1
- WHUVELXMYANGQP-UHFFFAOYSA-N N#Cc1nc(OCCN2CCCCC2)cc(-c2cccc(C(F)(F)F)c2)n1 Chemical compound N#Cc1nc(OCCN2CCCCC2)cc(-c2cccc(C(F)(F)F)c2)n1 WHUVELXMYANGQP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Description
Claims (7)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05108810 | 2005-09-23 | ||
EP05108810.2 | 2005-09-23 | ||
PCT/EP2006/066562 WO2007039470A1 (en) | 2005-09-23 | 2006-09-21 | 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101268058A CN101268058A (zh) | 2008-09-17 |
CN101268058B true CN101268058B (zh) | 2013-02-27 |
Family
ID=35466129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800348456A Expired - Fee Related CN101268058B (zh) | 2005-09-23 | 2006-09-21 | 4-苯基-6-取代的-嘧啶-2-腈衍生物 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1928842B1 (zh) |
JP (1) | JP5060484B2 (zh) |
KR (1) | KR20080046716A (zh) |
CN (1) | CN101268058B (zh) |
AR (1) | AR056086A1 (zh) |
AT (1) | ATE449080T1 (zh) |
AU (1) | AU2006298775A1 (zh) |
BR (1) | BRPI0616186A2 (zh) |
CA (1) | CA2621040C (zh) |
DE (1) | DE602006010581D1 (zh) |
ES (1) | ES2334714T3 (zh) |
HK (1) | HK1124319A1 (zh) |
IL (1) | IL189893A0 (zh) |
NO (1) | NO20081128L (zh) |
NZ (1) | NZ566475A (zh) |
PE (1) | PE20070438A1 (zh) |
TW (1) | TW200745055A (zh) |
WO (1) | WO2007039470A1 (zh) |
ZA (1) | ZA200802088B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1599468T3 (da) | 2003-01-14 | 2008-02-04 | Arena Pharm Inc | 1,2,3-trisubstituerede aryl- og heteroarylderivater som modulatorer af metabolisme og forebyggelse og behandling af forstyrrelser forbundet dermed såsom diabetes og hyperglykæmi |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
EP2287166A3 (en) | 2003-07-14 | 2011-06-22 | Arena Pharmaceuticals, Inc. | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
JP2009541284A (ja) * | 2006-06-23 | 2009-11-26 | アストラゼネカ・アクチエボラーグ | プテリジン誘導体およびカテプシン阻害剤としてのそれらの使用 |
JP5693452B2 (ja) | 2008-08-04 | 2015-04-01 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | 特定のキヌレニン−3−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法 |
CA2787365A1 (en) | 2010-01-25 | 2011-07-28 | Chdi Foundation, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
US10894787B2 (en) | 2010-09-22 | 2021-01-19 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
US8524710B2 (en) * | 2010-11-05 | 2013-09-03 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
WO2013033085A1 (en) | 2011-08-30 | 2013-03-07 | Stephen Martin Courtney | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
EA201490279A1 (ru) | 2011-08-30 | 2014-08-29 | Схди Фаундейшн, Инк. | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения |
US9328118B2 (en) * | 2012-04-17 | 2016-05-03 | Astellas Pharma Inc. | Nitrogen-containing bicyclic aromatic heterocyclic compound |
CN114588157A (zh) | 2014-07-17 | 2022-06-07 | Chdi基金会股份有限公司 | 用于治疗hiv相关病症的方法和组合物 |
WO2016112075A1 (en) | 2015-01-06 | 2016-07-14 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
SI3310760T1 (sl) | 2015-06-22 | 2023-02-28 | Arena Pharmaceuticals, Inc. | Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1 |
CA3053418A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
EP3778576B1 (en) | 2018-03-28 | 2024-04-17 | Hanlim Pharmaceutical Co., Ltd. | 2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004000819A1 (en) * | 2002-06-24 | 2003-12-31 | Astrazeneca Ab | New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
WO2004020441A1 (en) * | 2002-08-30 | 2004-03-11 | Novartis Ag | Hetereoaryl nitrile derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036375A1 (es) * | 2001-08-30 | 2004-09-01 | Novartis Ag | Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos |
GB0121033D0 (en) * | 2001-08-30 | 2001-10-24 | Novartis Ag | Organic compounds |
SE0201980D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
-
2006
- 2006-09-14 TW TW095134051A patent/TW200745055A/zh unknown
- 2006-09-21 EP EP06806788A patent/EP1928842B1/en not_active Not-in-force
- 2006-09-21 WO PCT/EP2006/066562 patent/WO2007039470A1/en active Application Filing
- 2006-09-21 AU AU2006298775A patent/AU2006298775A1/en not_active Abandoned
- 2006-09-21 JP JP2008531697A patent/JP5060484B2/ja not_active Expired - Fee Related
- 2006-09-21 DE DE602006010581T patent/DE602006010581D1/de active Active
- 2006-09-21 CN CN2006800348456A patent/CN101268058B/zh not_active Expired - Fee Related
- 2006-09-21 ES ES06806788T patent/ES2334714T3/es active Active
- 2006-09-21 KR KR1020087008796A patent/KR20080046716A/ko not_active Application Discontinuation
- 2006-09-21 BR BRPI0616186-3A patent/BRPI0616186A2/pt not_active IP Right Cessation
- 2006-09-21 AT AT06806788T patent/ATE449080T1/de not_active IP Right Cessation
- 2006-09-21 CA CA2621040A patent/CA2621040C/en not_active Expired - Fee Related
- 2006-09-21 NZ NZ566475A patent/NZ566475A/en unknown
- 2006-09-22 PE PE2006001151A patent/PE20070438A1/es not_active Application Discontinuation
- 2006-09-25 AR ARP060104157A patent/AR056086A1/es unknown
-
2008
- 2008-03-03 IL IL189893A patent/IL189893A0/en unknown
- 2008-03-04 NO NO20081128A patent/NO20081128L/no not_active Application Discontinuation
- 2008-03-05 ZA ZA200802088A patent/ZA200802088B/xx unknown
-
2009
- 2009-02-18 HK HK09101523.5A patent/HK1124319A1/xx not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004000819A1 (en) * | 2002-06-24 | 2003-12-31 | Astrazeneca Ab | New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
WO2004020441A1 (en) * | 2002-08-30 | 2004-03-11 | Novartis Ag | Hetereoaryl nitrile derivatives |
Also Published As
Publication number | Publication date |
---|---|
AR056086A1 (es) | 2007-09-19 |
CA2621040A1 (en) | 2007-04-12 |
ES2334714T3 (es) | 2010-03-15 |
HK1124319A1 (zh) | 2009-07-10 |
JP5060484B2 (ja) | 2012-10-31 |
ATE449080T1 (de) | 2009-12-15 |
JP2009508912A (ja) | 2009-03-05 |
PE20070438A1 (es) | 2007-06-13 |
AU2006298775A1 (en) | 2007-04-12 |
WO2007039470A1 (en) | 2007-04-12 |
IL189893A0 (en) | 2008-08-07 |
CN101268058A (zh) | 2008-09-17 |
ZA200802088B (en) | 2008-11-26 |
BRPI0616186A2 (pt) | 2011-06-07 |
NO20081128L (no) | 2008-06-18 |
EP1928842A1 (en) | 2008-06-11 |
EP1928842B1 (en) | 2009-11-18 |
DE602006010581D1 (de) | 2009-12-31 |
CA2621040C (en) | 2014-01-28 |
TW200745055A (en) | 2007-12-16 |
KR20080046716A (ko) | 2008-05-27 |
NZ566475A (en) | 2010-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101268058B (zh) | 4-苯基-6-取代的-嘧啶-2-腈衍生物 | |
JP4854943B2 (ja) | ジペプチジルペプチダーゼ阻害剤 | |
JP4836945B2 (ja) | 異常脂質血症を治療するための化合物および方法 | |
CN103415513B (zh) | 白三烯产物的苯并二氧杂环己烷抑制剂 | |
JP4559737B2 (ja) | N−アミノアセチル−ピロリジン−2−カルボニトリルおよびddp−iv阻害剤としてのその使用 | |
US7326715B2 (en) | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives | |
EP1148053A1 (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
KR20140143160A (ko) | B형 간염 바이러스 감염의 치료 및 예방을 위한 신규한 4-메틸-다이하이드로피리미딘 | |
WO2006073167A1 (ja) | ピロリジン誘導体 | |
CN103402987A (zh) | 6-氨基-2-苯基氨基-1h-苯并咪唑-5-甲酰胺衍生物及其作为微粒体前列腺素e2合酶-1抑制剂的用途 | |
HU211968A9 (en) | Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract | |
CN101230059B (zh) | 双环氮杂烷类衍生物、其制备方法及其在医药上的用途 | |
CN104860924A (zh) | 黑皮质素受体调节剂、制备它们的方法及其在人用药物和化妆品中的用途 | |
JP2014518853A (ja) | 新規な二環式窒素含有ヘテロアリールtgr5受容体調節因子 | |
WO2006137465A1 (ja) | 含窒素複素環誘導体 | |
EP3160961B1 (en) | Small molecule agonists of neurotensin receptor 1 | |
CN102216279A (zh) | 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途 | |
EP3126361A1 (en) | Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators | |
AU2022217353A1 (en) | Pyridopyrimidinone derivative, preparation method therefor, and use thereof | |
CN101973998A (zh) | 吡咯并嘧啶A2b选择性拮抗剂化合物 | |
CN101307046A (zh) | 三肽酶抑制剂 | |
EP3372589B1 (en) | Pyrimidine derivative | |
JP2008516976A (ja) | 抗増殖活性を有するインダンアミド | |
WO1999025712A1 (fr) | Nouveaux composes d'amide et medicaments contenant ces derniers | |
KR20060009933A (ko) | 시아노플루오로피롤리딘 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1124319 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Holland Applicant after: N.V. Organon Address before: Holland Applicant before: N.V. ORGANON |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: ORGANON NV TO: MSD OS CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ORGANON BIOLOGICAL NETHERLANDS CO., LTD. Free format text: FORMER NAME: MSD OUSI CO., LTD. Owner name: MERCK SHARP + DOHME CORP. Free format text: FORMER NAME: ORGANON BIOLOGICAL NETHERLANDS CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Haarlem Patentee after: MERCK SHARP & DOHME B.V. Address before: Haarlem Patentee before: Organon biological science Holland Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: Haarlem Patentee after: Organon biological science Holland Co.,Ltd. Address before: Holland Patentee before: N.V. Organon |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1124319 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130227 Termination date: 20140921 |
|
EXPY | Termination of patent right or utility model |